Haleon plc: disposal of the ChapStick brand completed

31 May 2024: Haleon plc ("Haleon") has today announced that it has completed the disposal of the ChapStick brand to Suave Brands Company, a portfolio company of Yellow Wood Partners.

On 25 January 2024, Haleon announced that it had reached a binding agreement for the sale of the ChapStick brand to Suave Brands Company for pre-tax cash proceeds of approximately $430 million, as well as a passive minority interest in Suave Brands Company.

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com.